Correlation Between Krebs Biochemicals and GACM Technologies

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Krebs Biochemicals and GACM Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Krebs Biochemicals and GACM Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Krebs Biochemicals and and GACM Technologies Limited, you can compare the effects of market volatilities on Krebs Biochemicals and GACM Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Krebs Biochemicals with a short position of GACM Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Krebs Biochemicals and GACM Technologies.

Diversification Opportunities for Krebs Biochemicals and GACM Technologies

-0.13
  Correlation Coefficient

Good diversification

The 3 months correlation between Krebs and GACM is -0.13. Overlapping area represents the amount of risk that can be diversified away by holding Krebs Biochemicals and and GACM Technologies Limited in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on GACM Technologies and Krebs Biochemicals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Krebs Biochemicals and are associated (or correlated) with GACM Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of GACM Technologies has no effect on the direction of Krebs Biochemicals i.e., Krebs Biochemicals and GACM Technologies go up and down completely randomly.

Pair Corralation between Krebs Biochemicals and GACM Technologies

Assuming the 90 days trading horizon Krebs Biochemicals and is expected to generate 2.23 times more return on investment than GACM Technologies. However, Krebs Biochemicals is 2.23 times more volatile than GACM Technologies Limited. It trades about 0.18 of its potential returns per unit of risk. GACM Technologies Limited is currently generating about -0.11 per unit of risk. If you would invest  8,437  in Krebs Biochemicals and on September 3, 2024 and sell it today you would earn a total of  1,977  from holding Krebs Biochemicals and or generate 23.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Krebs Biochemicals and  vs.  GACM Technologies Limited

 Performance 
       Timeline  
Krebs Biochemicals and 

Risk-Adjusted Performance

8 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Krebs Biochemicals and are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. Despite fairly weak fundamental drivers, Krebs Biochemicals demonstrated solid returns over the last few months and may actually be approaching a breakup point.
GACM Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GACM Technologies Limited has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

Krebs Biochemicals and GACM Technologies Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Krebs Biochemicals and GACM Technologies

The main advantage of trading using opposite Krebs Biochemicals and GACM Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Krebs Biochemicals position performs unexpectedly, GACM Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in GACM Technologies will offset losses from the drop in GACM Technologies' long position.
The idea behind Krebs Biochemicals and and GACM Technologies Limited pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope